Numerous mechanisms have been found linking dementia and type 2 diabetes, including vascular compromise, hypoglycemia, and insulin resistance. Therefore, anti-glycemic drugs could potentially have ...

These new immunotherapy drugs trigger the body’s immune system to break ... although evidence on their effectiveness is limited. “We think that the mechanism of vascular dementia is increasing ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...

An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease.

For the first time, scientists have developed a drug that works on both major aggregation-promoting "hotspots" of the Tau protein - addressing a critical gap in current treatments.

Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...

RESEARCHERS have developed a drug that successfully blocks two major Alzheimer’s disease “hotspots” at once, in a “promising” breakthrough against the brain robbing ...

Developed by international researchers led by British experts, RI-AG03, tackles two 'hotspots' on the protein that leads to ...

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.